Rivaroxaban Versus Warfarin in Nonvalvular Atrial Fibrillation

Yearbook of Cardiology
doi 10.1016/j.ycar.2012.02.044
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Warfarin Versus Warfarin and Aspirin in Atrial Fibrillation

Neurological Bulletin
2011English

Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2017English

Estimating an Icer With NOAC Versus Warfarin in Atrial Fibrillation

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Comparison of Bleeding in Patients With Nonvalvular Atrial Fibrillation Treated With Ximelagatran or Warfarin

Archives of Internal Medicine
2006English

Suboptimal Anticoagulant Management in Japanese Patients With Nonvalvular Atrial Fibrillation Receiving Warfarin for Stroke Prevention

Journal of Stroke and Cerebrovascular Diseases
SurgeryNeurologyCardiovascular MedicineRehabilitationCardiology
2017English

Patient Satisfaction After Switching From Warfarin to Apixaban in Patients With Nonvalvular Atrial Fibrillation: AGAIN Study

Patient Preference and Adherence
PharmacologyHealth PolicyMedicineToxicologySocial SciencesPharmaceutics
2017English

Risk Stratification of Nonvalvular Atrial Fibrillation

Clinical and Applied Thrombosis/Hemostasis
MedicineHematology
2013English

Comparative Pharmacoeconomic Analysis of Rivaroxaban and Warfarin Usage in Patients With Non-Valvular Atrial Fibrillation

Jounal of arrhythmology
2020English

Prediction of Unstable Anticoagulation With Acenocoumarol Versus Warfarin in Atrial Fibrillation

Cardiology Journal
MedicineCardiovascular MedicineCardiology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy